{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.11"},{"groupId":"OG001","value":"12.50"},{"groupId":"OG002","value":"11.85"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"206"},{"groupId":"OG001","value":"176"},{"groupId":"OG002","value":"270"}],"units":"Participants"}],"description":"The Percentage of patients who experienced surgical or radiotherapy complications will be calculated. The complications are: bowel obstruction, chylous leaf, renal injury/atrophy/loss and diarrhea.","groups":[{"description":"Induction therapy + single myeloablative consolidation","id":"OG000","title":"Single HST (CEM)"},{"description":"Induction therapy + tandem myeloablative consolidation","id":"OG001","title":"Tandem HST (CEM), Randomly Assigned"},{"description":"Patients that either failed during Induction therapy or refused randomization","id":"OG002","title":"Not Assigned"}],"paramType":"NUMBER","populationDescription":"All eligible patients enrolled on ANBL0532.","reportingStatus":"POSTED","timeFrame":"Up to 3 years","title":"Type of Surgical or Radiotherapy Complication","type":"SECONDARY","unitOfMeasure":"Percentage of patients"}